We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mathematical Model Predicts Aggressiveness of Tumors

By Biotechdaily staff writers
Posted on 14 Dec 2006
Scottish researchers have developed a new mathematical model that predicts how tumors grow and invade tissue.

Their findings show that the aggressiveness of cancer tumors may be determined by the tissue environment in which the tumors grow. More...
The mathematical model developed by Dr. Sandy Anderson, of the division of mathematics at the University of Dundee (Scotland), and colleagues is similar in concept to weather forecasting but considerably more complex. The model was described in the December 1, 2006, issue of Cell.

"What this model predicts is that the more barren and harsh the tissue environment surrounding it is, the more aggressive the tumor becomes,” said Dr. Anderson.

The findings have the potential to influence the treatment of certain cancers by forcing the environment around the tumor to be considered as a contributory factor in how aggressive the cancer is. The combination of math and laboratory research to develop a model such as this one has been hailed as a "new era in cancer research” by Prof. Vito Quaranta, a leading American cancer biologist who is collaborating on the project.

Prof. Quaranta envisions a future when computer simulations like this will be used to predict a tumor's clinical progression and formulate treatment plans, in a fashion not dissimilar to how we forecast the weather now.

"Today we can know pretty well that for the next few days we're going to expect good weather or that there's a storm on the way,” said Prof. Quaranta. "That's the kind of predictive power we want to generate with our model for cancer invasion.”

"What our research shows is that the micro-environment in which the tumor grows acts like a Darwinian selective force upon how the tumor evolves,” added Dr. Anderson. "Much of current biomedical research being carried out on cancer is done in isolation of the real environment in which the tumor naturally grows, but these results show that this environment could be the crucial determining factor in the tumor's development.”

The model developed by Dr. Anderson also showed a clear relationship between the shape of a cancer tumor and how aggressive it is. Aggressive tumors tend to assume a spidery shape in the model, while more benign growths are generally more spherical in shape.

"This is important in terms of the surgical removal of tumors,” explained Dr. Anderson. "A model like this could help predict how tumors will grow in different tissue environments, i.e., different areas of the body, and what the best strategy may be to treat them. One interesting aspect of this is that if you make the environment the tumor is growing in more harsh or barren, then the more likely it is that any surviving cancer cells will be the most aggressive and hardiest ones.”

"In the future this research could help tailor treatment in a patient-specific manner, with the mathematical model being an additional weapon in the armory against cancer,” added Dr. Anderson.



Related Links:
University of Dundee

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.